|
(MoneyNewsWire.Net, July 27, 2017 ) According to the report Latin America Liquid Biopsy, published by Market Data Forecast, the global market is projected to reach USD 319.43 million by 2021, at a CAGR of 27.6% from 2016 to 2021.
This technology of liquid biopsy has enormous diagnostic and treatment implications for oncology and it is believed to transform clinical practice. A liquid biopsy, may capture the entire heterogeneity of the disease. This methodology is advantageous over tissue biopsies as monitoring of tumour genomic can be done by taking serial samples.
Liquid biopsy Market tests are executed to understand the molecular aspects of cancer across the healthcare and research settings, such as hospitals, physicians, pathological and research laboratories. It is a non-invasive blood test that could provide researchers, physicians, and surgeons with information about the cancer profile of the patient and appropriate therapy to improve the survival rate of the cancer patients. It is a rapid process that usually includes a simple blood draw, extraction of nucleic acids from the blood plasma, and amplification of the molecular targets to permit analysis of the defined biomarkers.
Get a comprehensive overview of the Latin America Liquid Biopsy Market: http://www.marketdataforecast.com/market-reports/latin-america-liquid-biopsy-market-954/
Latin America Liquid Biopsy Market: Drivers & Restraints
Liquid biopsy provides crucial information about the treatment taken by a patient which helps the doctors to identify whether a patient's cancer is responsive or resistant to a drug and then make a switch if needed. This is a key driving force for the use of liquid biopsy as this advancement was not provided by tissue biopsies. Lack of documented evidence about the efficacy of the process is the factor hindering the growth of liquid biopsy market.
Get accurate market forecast and analysis on the Latin America Liquid Biopsy Market. Request a sample to stay up-to-date on the main trends affecting this market http://www.marketdataforecast.com/market-reports/latin-america-liquid-biopsy-market-954/request-sample
Latin America Liquid Biopsy Market: Segmentation
By Cancer Type
Lung Cancer
Pancreatic Cancer
Leukemia
Other Visceral Cancers
By Sample Type
Blood
Urine
Plasma
Saliva
Cerebrospinal
By Diagnostic Approach
Circulating Tumour cells (CTC)
Circulating Tumour DNA (ctDNA)
RNA in exosomes
Extra-Cellular Vesicles
By End Users
Reference Laboratories
Hospital/Physician Laboratories
Academic and Research Centers
Other End Users
From simple data collation through secondary and primary research to ad-hoc research requests relating to specific information, we provide our services via customization. Get customization at http://www.marketdataforecast.com/market-reports/latin-america-liquid-biopsy-market-954/customize-report
Latin America Liquid Biopsy Market: Overview
CTCs (Circulating Tumour cells), the first such entities on the liquid biopsy scene, have accounted for a large share in the market. Cancer institute is the largest end user segment in terms of revenues and is expected to create substantial opportunity in global liquid biopsy market over the forecast period. Therapy selection for metastatic cancer and cancer monitoring are key applications of liquid biopsies. Most liquid biopsy tests are expected to be blood sample based. A high number of tests under development that use Circulating tumor DNA as biomarker for liquid biopsy.
Multiple gene analysis using NGS technology expected to have higher market application for liquid biopsies. A number of market entities are involved in observational & investigative clinical trials for the development of liquid biopsy tests. Furthermore, the growing concern to reduce cancer mortality, and the need to reduce complications associated to conventional biopsies are major factors expected to drive development over the coming years.
Latin America Liquid Biopsy Market: Region-wise Outlook
Latin America market is geographically segmented into Mexico, Brazil and Argentina. All major action in the field of liquid biopsy is expected to emerge from latin America region over the forecast period. However, increasing funding for private public partnerships in field of cancer research is expected to fuel the latin America Market.
Key Questions Answered
What will be the market growth till 2021 and what will be the resultant market forecast in the year?
What was the market size from 2016 to 2021 ?
What is the current and future Liquid Biopsy Market outlook in Latin America? What trends are affecting the latin America market?
What is the competitive landscape and market share of major players in the Liquid Biopsy space in latin America?
What are the key, high growth markets that Liquid Biopsy manufacturers should expand into? Which market segments are growing the fastest?
What are the unmet needs with the Liquid Biopsy currently on the market? How will emerging technologies fulfil these unmet needs?
What is physician perception and market outlook of Liquid Biopsy?
What are the challenges and barriers that have hindered widespread adoption of Liquid Biopsy?
Latin America Liquid Biopsy Market: Key Players
The key players dominating the liquid biopsy market are Janssen Diagnostics, Qiagen, Rarecells SAS, Silicon Biosystems, SRI International, Myriad Genetics, Natera, Personal Genome Diagnostics, Sysmex Inostics, Trovagene, Exosome Diagnostics, Exosome Sciences, and HansaBiomed OU.
Reasons to buy Latin America Liquid Biopsy Market Report:
Global, regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering
Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porters Five Forces Analyses
A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Diagnostics Segment:
Latin America HIV Diagnostics Market: http://www.marketdataforecast.com/market-reports/latin-america-hiv-diagnostics-market-2149/
Latin America In-Vitro Diagnostics Market: http://www.marketdataforecast.com/market-reports/latin-america-in-vitro-diagnostics-market-150/
Latin America Genetic Testing Market: http://www.marketdataforecast.com/market-reports/latin-america-genetic-testing-market-40/
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options.
For more information, kindly visit, www.marketdataforecast.com
Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
|
